Li Ren Kong
- Molecular Biology top 10%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Immunology top 10%
- Topics
- Lung Cancer Treatments and Mutations (14 papers)Lung Cancer Diagnosis and Treatment (11 papers)Esophageal Cancer Research and Treatment (7 papers)
- Partner nations
- ChinaSingaporeUnited States
In The Last Decade
Li Ren Kong
72 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 111
- Molecular Biology 887
- Oncology 646
- Pulmonary and Respiratory Medicine 501
- Cancer Research 476
- Immunology 224
Countries citing papers authored by Li Ren Kong
This map shows the geographic impact of Li Ren Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Ren Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Ren Kong more than expected).
Fields of papers citing papers by Li Ren Kong
This network shows the impact of papers produced by Li Ren Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Ren Kong. The network helps show where Li Ren Kong may publish in the future.
Co-authorship network of co-authors of Li Ren Kong
This figure shows the co-authorship network connecting the top 25 collaborators of Li Ren Kong. A scholar is included among the top collaborators of Li Ren Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Ren Kong. Li Ren Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 48 | |
| 7 | 29 | |
| 8 | 11 | |
| 9 | 31 | |
| 10 | 91 | |
| 11 | 69 | |
| 12 | 12 | |
| 13 | 3 | |
| 14 | 41 | |
| 15 | 14 | |
| 16 | 35 | |
| 17 | 41 | |
| 18 | 219 | |
| 19 | 20 | |
| 20 | 23 |
About Li Ren Kong
Li Ren Kong is a scholar working on Cancer Research, Otorhinolaryngology and Pulmonary and Respiratory Medicine, having authored 77 papers that have together received 2.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Diagnosis and Treatment (11 papers) and Esophageal Cancer Research and Treatment (7 papers). The work is most often cited by research in Cancer Research (476 citations), Oncology (646 citations) and Pulmonary and Respiratory Medicine (501 citations). Li Ren Kong has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Liu C, Feifei Teng, Boon Cher Goh, Jinming Yu, Xiangjiao Meng, Yi Luan, Xiaohui Bai, Edward Lin, Andrea Li‐Ann Wong and Lingzhi Wang. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.